一般描述
A benzylphthalazinyl compound that blocks the binding of the Smoothened (Smo) agonist Hh-Ag1.5 to Smo in competitive binding assays (IC50 = 5 or 8 nM, respectively, using CHO-K1 membrane expressing murine or human Smo) and potently inhibits Gli-mediated transcription activity upon Hh-Ag1.5 stimulation in TM3-based reporter assays (IC50 = 2.7 or 35 nM, respectively, against 1 or 25 nM Hh-Ag1.5). Shown to exhibit blood-brain barrier permeability and good oral bioavailability in mice and effectively inhibit tumor growth in a dose-dependent manner in a Ptch+/-p53-/- medulloblastoma allograft model in Harlan nu/nu mice (71% regression by two 40 mg/kg oral dosages per day) in vivo.
制备说明
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
法规信息
监管及禁止进口产品
此项目有
Karen Miller-Moslin et al.
Journal of medicinal chemistry, 52(13), 3954-3968 (2009-05-28)
Abnormal activation of the Hedgehog (Hh) signaling pathway has been linked to several types of human cancers, and the development of small-molecule inhibitors of this pathway represents a promising route toward novel anticancer therapeutics. A cell-based screen performed in our
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持